Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.0405189 on October 4, 2005

Published online before print October 4, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0405189v1
78/5/1097    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karacsonyi, C.
Right arrow Articles by Lindner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karacsonyi, C.
Right arrow Articles by Lindner, R.
(Journal of Leukocyte Biology. 2005;78:1097-1105.)
© 2005 by Society for Leukocyte Biology

MHC II molecules and invariant chain reside in membranes distinct from conventional lipid rafts

Claudia Karacsonyi*, Tanja Bedke{dagger}, Nils Hinrichsen{ddagger}, Reinhard Schwinzer{dagger} and Robert Lindner*,1

* Department of Cell Biology in the Center of Anatomy and
{dagger} Transplantationslabor, Klinik für Viszeral- und Transplantationschirurgie, Hannover Medical School, Germany; and
{ddagger} Department of Food Chemistry, University of Hamburg, Germany

1Correspondence: Department of Cell Biology in the Center of Anatomy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. E-mail: rli{at}zellbiologie.mh-hannover.de


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Major histocompatibility complex class II (MHC II) peptide complexes can associate with lipid rafts, and this is a prerequisite for their recruitment to the immunological synapse and for efficient T cell stimulation. One of the most often used criterion for raft association is the resistance to extraction by the detergent Triton X-100 (TX-100) at low temperature. For MHC II, a variety of detergents have been used under different conditions, leading to variable and often conflicting conclusions about the association of MHC II with detergent-resistant membranes (DRMs). To clarify whether these inconsistencies were caused by variations in the isolation protocols or reflect different biochemical properties of MHC II lipid complexes, we used two standardized procedures for the isolation of membranes resistant to TX-100, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), or Brij 98. Our results suggest that some of the reported variations in the association of MHC II with DRMs are caused by differences in the methods. We also show that in our hands, specific and efficient flotation of MHC II and the MHC II-associated invariant chain from mouse B-lymphoma cells was only achieved with Brij 98, but not with TX-100 and CHAPS. We furthermore used DRMs prepared from hen egg lysozyme-fed B-lymphoma cells to activate the T cell hybridoma 3A9. In agreement with our biochemical data, T cell activation could only be achieved with Brij 98- but not with TX-100-resistant membranes. Thus, MHC II and also the invariant chain belong to a set of proteins comprising the T cell receptor, prominin, and the prion protein, which reside in membrane environments distinct from conventional lipid rafts.

Key Words: antigen presentation • membrane microdomain • detergent resistance • GEMs • DIGs


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Major histocompatibility complex class II (MHC II) molecules are transmembrane proteins, which present antigens to CD4+ T cells [1 ]. MHC II is synthesized in the endoplasmic reticulum (ER), where it associates with the chaperone invariant chain. This molecule has three main functions; first, it promotes MHC II folding; second, it prevents ER peptides from binding to MHC II; and third, it is required for trafficking of the complex through the trans Golgi network to early endosomes [2 ]. Eventually, these early endosomes mature to form multivesicular bodies, where the invariant chain is degraded, allowing the loading of MHC II with antigenic peptides. From there, MHC II is transported to the cell surface by a yet unknown mechanism [3 , 4 ]. At the cell surface, MHC II has been shown to be associated with specific membrane domains termed "lipid rafts" [5 6 7 8 9 ]. Moreover, it has been proposed that clustering of surface MHC II into lipid rafts is essential for specific T cell activation at low antigen concentration [6 , 10 ].

Lipid rafts are membrane domains, which are enriched in cholesterol and sphingolipids and contain a specific subset of membrane proteins including glycophosphatidylinositol-anchored proteins (GPIs) [11 12 13 ]. It is believed that the long and saturated acyl chains of sphingolipids pack with cholesterol and thus promote the formation of a liquid-ordered phase, whereas unsaturated glycerophospholipids favor a more fluidic state of cell membranes. Recently, evidence was provided for precursors of lipid rafts, which are ~5 nm in size, contain only one to four proteins, and persist less than a millisecond [14 , 15 ]. After ligand- or antibody-mediated cross-linking, the precursors are thought to fuse and form larger and more permanent structures, which can be visualized as rafts by immunofluorescence techniques at the cell surface. They have been shown to serve as platforms for signaling and protein sorting [16 17 18 ]. Operationally, lipid rafts can be defined as detergent-resistant membranes (DRMs) as a result of their partial resistance to solubilization by mild detergents [13 ]. It is still a matter of controversy how closely DRMs resemble native lipid rafts, but it should be kept in mind that many of the proteins and lipids that associate with rafts after antibody-mediated cross-linking or ligand-induced oligomerization are found in DRMs. This suggests that the isolation of membrane domains with detergents may result in the formation of raft-like structures similar to those obtained after experimental or ligand-induced cross-linking at the cell surface. Over the last years, evidence had accumulated that there might be diverse types of lipid rafts and correspondingly, also different types of DRMs [19 20 21 22 23 24 25 ]. It is interesting that some DRMs appear to be resistant only to weak detergents such as Lubrol WX, Brij 96, and Brij 98 but are solubilized by stronger detergents such as Triton X-100 (TX-100).

In a number of studies, the association of MHC II with TX-100-resistant membranes was examined; however, the results varied greatly. In many instances, only 1–5% of total MHC II was found in TX-100-resistant membranes [8 , 26 27 28 29 ], whereas in other studies, a substantial amount of MHC II (more than 10%) was detected in TX-100-resistant membranes [5 , 6 , 10 , 29 , 30 ]. In addition to TX-100, other detergents, such as 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) [31 ], Brij 58 [32 ], and Brij 98 [9 ], have been used for the isolation of DRMs containing MHC II. With these detergents, a high fraction of MHC II (~60%) was found to be associated with DRMs. Currently, it is not clear to what extent these differences were caused by variations in the isolation protocols rather than by biochemical properties of membranes containing MHC II and the invariant chain or by differences in cell lines and their signaling and/or activation status. For that reason, we compared isolation efficiencies and specificities using membrane preparations from mouse B-lymphoma cells, which were extracted with TX-100, CHAPS, or Brij 98. In addition, for every detergent, two variants of the DRM flotation protocol were tested. Our results demonstrate a large difference in efficiency and specificity of isolation of MHC II- and invariant chain-containing DRMs between the different protocols using TX-100, CHAPS, and Brij 98. This suggests that MHC II- and invariant chain-containing DRMs may share properties with DRMs occupied by the T cell receptor (TCR) complex [22 ], prominin [20 ], or the prion protein [19 , 25 ].


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Cells, antibodies, and reagents
The cell lines M12.C3.F6 [33 ], 3A9 [34 ], 10.2.16 (anti-mouse MHC II Ak ß-chain) [35 ], and In-1 (anti-mouse invariant chain) [36 ] were cultured in RPMI-1640 GlutaMAX I supplemented with 1 mM pyruvate, 100 units/ml penicillin, 100 µg/ml streptomycin, 10 mM HEPES, 50 µM ß-mercaptoethanol (all from Invitrogen, Carlsbad, CA), and 10% fetal calf serum (Biochrom, Berlin, Germany). The interleukin (IL)-2-dependent cell line cytotoxic T cell (CTLL)-2 [37 ] was cultured in the medium specified above plus 2 U/ml human IL-2 (Biotest, Dreieich, Germany). The monoclonal antibody (mAb) against lysosome-associated membrane protein (lamp)-1 (1D4B) developed by J. T. August was obtained from the Developmental Studies Hybridoma Bank (Iowa City, IA). Cholera toxin B subunit (CTB) and the anti-CTB antibody were obtained from Quadratech (Epsom, UK). The anti-B220 mAb RA3-6B2 was purchased from PharMingen (San Diego, CA). The anti transferrin receptor mAb H68.4 was from Zymed Laboratories (San Francisco, CA). Secondary horseradish peroxidase-conjugated antibodies were bought from Dianova (Hamburg, Germany). Enhanced chemiluminescence (ECL) film and [3H] thymidine were from Amersham Biosciences (Little Chalfont, UK), and Western Lightning ECL reagent, from PerkinElmer Life and Analytical Sciences (Boston, MA). Sucrose and DNase I were obtained from Calbiochem (San Diego, CA). Hen egg lysozyme (HEL) and lipid standards [phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), sphingomyelin (Sm), and cholesterol] were bought from Sigma Chemical Co. (St. Louis, MO). Phosphatidylserine (PS) was from Fluka (St. Louis, MO). High-performance thin-layer chromatography (HPTLC) 20 x 20 cm aluminum sheets, coated with silica gel 60, were purchased from Merck (Rahway, NJ). All other chemicals were of analytical grade and were obtained from Sigma Chemical Co., Merck/VWR, or J. T. Baker (Phillipsburg, NJ).

Isolation of DRMs
M12.C3.F6 B-lymphoma cells (3x107) were washed and resuspended in 1 ml 10 mM triethanolamine/acetic acid, 1 mM EDTA, and 250 mM sucrose, pH 7.4, supplemented with protease inhibitors (5.1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml E-64, 0.1 mM phenylmethylsulfonyl fluoride, and 5 mM iodoacetamide; HB-T+). In this buffer, the cells were homogenized by repeated passage through a 23-gauge needle, and a postnuclear supernatant was prepared (1000 g, 10 min, 4°C). After re-extraction of the nuclear pellet with 200 µl HB-T+, the combined supernatants were digested with 100 µg/ml DNase I for 1 h on ice. Postnuclear membranes were pelleted (40,000 rpm, 45 min, 4°C) in a TLA 45 rotor (Beckman Coulter, Fullerton, CA) and resuspended in 500 µl 20 mM 2-[N-morpholino]ethanesulfonic acid (MES) acid, 150 mM NaCl, 0.02% NaN3, and protease inhibitors (MES+ buffer) or in MES+ buffer containing 1% TX-100, 1% or 4% CHAPS, or 1% Brij 98 for extraction. After addition of DNase I (100 µg/ml), the postnuclear membranes were extracted for 1 h on ice. For extraction with Brij 98, a 5-min incubation at 37°C was done before the 1-h incubation step on ice. After extraction, all samples were mixed with 500 µl 90% sucrose containing the same concentration of detergent as in the extraction and transferred to an SW-41 tube. A 10-ml, 0–40% gradient of sucrose in MES+ buffer with or without detergent was layered on top of the sample, which was then centrifuged (38,000 rpm, 18.5 h, 4°C) in an SW41 rotor (Beckman Coulter). Eleven fractions were collected from the top, and the pellet was resuspended in 1 ml extraction buffer.

Gel electrophoresis, blotting procedures, and quantification
Standard sodium dodecyl sulfate gel electrophoresis was performed in mini gels containing 11% polyacrylamide. For Western blotting, primary antibodies were used as recommended by the manufacturer or at 1 µg/ml. CTB was used at 1 µg/ml and the anti-CTB antiserum at a 1:2000 dilution. Secondary reagents were diluted according to the recommendations of the manufacturers. For dot blots, 3 µl each gradient fraction was spotted onto a nitrocellulose membrane, dried, and incubated with antibodies as described above. All blots were developed with ECL reagent and exposed to film. Suitable exposures were scanned and quantified using the program NIH Image.

Lipid analysis
DRM fractions were pooled, diluted with 1:3 with MES buffer, and spun for 2 h at 100,000 g at 4°C. Pellets were resuspended in 1.8 ml 0.9% and NaCl, 0.05% HCl ("salty acid") and transferred to glass tubes, and 2 ml methanol and 2 ml chloroform were added sequentially. After shaking, samples were incubated for 10 min on ice and spun for 5 min at 300 g. The upper phase was removed, and 2 ml methanol and 1.8 ml salty acid were added to the lower phase. Samples were again incubated and spun as above, and the upper phase together with the interphase were removed this time. Chloroform (1 ml) was added to the lower phase, and speed-vac centrifugation was performed. Dried pellets were resuspended in 20 µl chloroform, and 3 µl each sample was loaded onto HPTLC sheets. Lipids were resolved by using a two-solvent system. Samples were first run to the halfway point of the plate in a hydrophilic solvent (50:20:10:10:5 chloroform/acetone/acetic acid/methanol/water) and air-dried and finally, ran in a hydrophobic solvent (50:20 hexane/ethyl acetate). Lipids were visualized with the fluorescent dye primulin (0.05% in an 80:10 mixture of acetone and water, respectively), photographed with a digital camera, and quantified using NIH Image. The relative abundance of the lipids was calculated under the assumption that the molar primulin adsorption is similar among the lipids we analyzed.

Antigen presentation assays
As antigen-presenting cells (APCs), we used the B-lymphoma line M12.C3.F6, which had been cultured in the presence or the absence (controls) of 2 µM HEL for 24 h. After washing, 100 µl B cells (105cells/ml) were incubated with 50 µl 3A9 T hybridoma cells specific for the HEL peptide 48–62 (2x106 cells/ml) for 24 h at 37°C. Alternatively, after incubation with HEL, 3 x 107 APCs were processed for DRM isolation using MES+ buffer containing 1% of TX-100 or Brij 98 for extraction and 1% of each detergent in the gradient. The DRM fractions were identified by dot-blotting against GM1, pooled, diluted 1:3 with MES+ buffer, and pelleted by centrifugation at 90,000 rpm (TLA 100.4 Beckman rotor) for 1 h at 4°C. After washing two times in phosphate-buffered saline (PBS), the pelleted membranes were resuspended in 500 µl RPMI-1640 medium with all supplements (see above). The 3A9 cells were then incubated with 30 µl resuspended DRMs (approximately 1x106 cell equivalents, assuming a 50–60% isolation efficiency) for 24 h at 37°C in a cell-culture incubator. Supernatants were collected the following day and frozen at –20°C to kill any remaining cells. After thawing, 50 µl supernatants were incubated with 50 µl CTLL-2 cells (105 cells/ml) at 37°C in a cell-culture incubator. After 24 h, 20 µl solution of 0.05 µCi/µl [3H] thymidine was added to each sample, and the culture was continued for an additional 24 h. Finally, cells were harvested on glass fiber mats (Inotech, Dottikon, Switzerland), and the incorporated [3H] thymidine was measured in a Wallac-Trilux microbeta reader 1450.

Enzymatic reactions
For detection of alkaline phosphatase, 50 µl substrate containing 20 mM p-nitrophenylphosphate, 2 M diethanolamine, and 2.5 mM MgCl2, pH 9.8, was added to a 50-µl sample in a microtiter plate and incubated for 2–4 h at 37°C. Color development was read at 404 nm in an enzyme-linked immunosorbent assay reader.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
TX-100 has been the most popular detergent for isolating DRMs [38 ]. We therefore set out to determine whether MHC II and its chaperone invariant chain would float into a sucrose gradient using this detergent. Postnuclear membranes were extracted for 1 h on ice with 1% TX-100, loaded onto a 0–40% linear sucrose gradient lacking the detergent, and centrifuged to separate DRMs from soluble membranes. Western blots and enzymatic assays were performed to analyze the isolated fractions (Fig. 1A ). Most of the raft marker GM1 and ~30% of the GPI-anchored protein AP were found to float under these conditions, together with a low amount of MHC II. The TfnRC, a protein not considered to be a raft component at the plasma membrane [39 ], did not float appreciably under this condition. The high-mannose ER form and the mature form of invariant chain and the nonraft markers lamp-1 [9 , 40 ] and B220 [6 ] were detected in DRM fractions, at least to a similar extent as MHC II. Taking into consideration that ER proteins are not associated with lipid rafts [41 ], the latter result made it difficult to determine whether the small amount of MHC II in the gradients lacking the detergent reflected genuine or only nonspecific DRM association. To answer this question, we tried to increase the selectivity by including the detergent in the gradient (Fig. 1B) . Under these more stringent conditions, only the raft markers GM1 and AP were floating (albeit to a slightly lower extent), and the nonraft markers lamp-1 and B220 along with TfnRc, MHC II, and the invariant chain were found exclusively in the soluble fractions. Thus, the presence of detergent in the gradient prevented the low, nonspecific flotation of lamp-1, B220, and the immature ER form of the invariant chain as well as the flotation of small amounts of MHC II and the mature invariant chain. This suggests that the latter two proteins did not float specifically into the gradient when the detergent was absent. We speculate that the presence of detergent in the gradient may prevent reformation of membrane vesicles caused by the dilution of the detergent during flotation. Alternatively, the extended exposure to the detergent during centrifugation may lead to a solubilization of membranes, which resist the detergent for only a limited time. It is also possible that weakly DRM-associated proteins dissociate from the membranes under nonequilibrium conditions in the gradient. To investigate whether membrane lipids were affected by the presence of the detergent in the gradient, we analyzed the lipid composition of DRMs isolated in the presence or absence of 1% TX-100 from the gradient (Fig. 2 ). DRMs isolated in the presence of 1% TX-100 showed a higher enrichment in cholesterol (35% of the primulin signal for these DRMs) and Sm/PI (20%) compared with DRMs retrieved in the absence of detergent (cholesterol: 22%; Sm/PI: 12%) or total postnuclear membranes (cholesterol: 18%; Sm/PI: 10%). The enrichment of Sm/PI and cholesterol demonstrates that the presence of TX-100 in the gradient indeed influenced the membrane lipid composition. Thus, it is possible that the detergent in the gradients did not induce the dissociation of proteins from DRMs but instead, dissolved the membranes containing these proteins.



View larger version (60K):
[in this window]
[in a new window]
  		Figure 1. Flotation of TX-100-extracted, postnuclear membranes on linear 0–40% sucrose gradients in the absence (A) or the presence (B) of 1% TX-100 throughout the gradient. Postnuclear membranes were prepared from M12.C3.F6 mouse B-lymphoma cells, extracted in MES+ buffer containing 1% TX-100, and floated in 0–40% sucrose gradients with (B) or without (A) detergent. Individual fractions were analyzed by Western blotting with the mAb 10.2.16 (MHC II), In-1 (invariant chain), H86.4 [transferrin receptor (TfnRc)], 1D4B (lamp-1), or cholera toxin B-subunit (GM1) or by dot blotting with the mAb RA3-6B2 (B220). The raft marker alkaline phosphatase (AP) was quantified by enzyme assay. Note that in A, only little MHC II floated into the gradient along with a similar amount of lamp-1, B220, and TfnRc. Also note that no flotation of MHC II, invariant chain, or nonraft markers was found when TX-100 was present in the gradient (B). Iimat., Mature invariant chain; Iiimm., immature invariant chain (ER form); a.u., arbitrary units; OD, optical density; p, pellet.

 


View larger version (21K):
[in this window]
[in a new window]
  		Figure 2. Lipid composition of TX-100-resistant membranes isolated from gradients with or without detergent in comparison with total postnuclear membranes. Lipids were extracted from membrane pellets as described in Materials and Methods, separated by HPTLC, stained with primulin, and quantified with NIH Image. The relative abundance of lipids was calculated under the assumption that all lipids showed a similar molar primulin adsorption. Sm and PI were not separated sufficiently in our solvent system and thus, were quantified together. The data represent the mean of three independent experiments, and error bars indicate the SD. Note that DRMs isolated in the continued presence of TX-100 contain the highest relative amount of cholesterol and Sm/PI but the lowest relative amount of PC and PE.

 
Extraction of cells with CHAPS has been recommended as an alternative to TX-100 [38 ]. We therefore investigated whether CHAPS would be useful for the isolation of DRMs containing MHC II and the invariant chain. Figure 3 shows the distribution of several markers after extracting postnuclear membranes for 1 h on ice with MES+ buffer containing 1% CHAPS. Gradients were again prepared in the presence or absence of detergent. Under both conditions, the raft markers GM1 and AP floated broadly throughout the gradient; however, in the presence of the detergent, the zone of the raft markers did not float as far up the gradient as in the absence of detergent. In addition, the nonraft marker lamp-1 together with TfnRc, MHC II, and both forms of the invariant chain partially distributed to the lower end of these DRM fractions. The nonraft marker B220 was absent from the gradient containing the detergent (Fig. 3B) , indicating that the presence of CHAPS in the gradient conferred a somewhat higher selectivity. However, the presence of the nonraft markers lamp-1 and the immature invariant chain in the DRM fractions suggested that CHAPS was not selective enough under both conditions tested. There is one report that described the use of 4% CHAPS instead of 1% for the isolation of DRMs [38 ]. Increasing the ratio of detergent to membranes may be important for achieving higher selectivity with CHAPS. We therefore extracted postnuclear membranes of M12.C3.F6 cells with 4% CHAPS and subjected them to flotation in a 0–40% sucrose gradient with or without CHAPS (Fig. 4 ). In the absence of detergent from the gradient (Fig. 4A) , only a minor fraction of GM1 and AP was floating into the gradient, suggesting that extraction by 4% CHAPS caused a substantial solubilization of lipid rafts. Under this condition, only a small amount of lamp-1 and immature invariant chain, but no B220, cofloated with AP-containing fractions, confirming that CHAPS indeed might be more selective. Unfortunately, little MHC II and only some invariant chain, enriched in the slower migrating, mature form, were found in the gradient. Given the low amounts of MHC II and mature invariant chain in the DRM fractions, it was again difficult to decide whether their flotation was a result of genuine DRM association or caused by a nonspecific effect as we discussed with Figure 1 . The presence of 4% CHAPS throughout the gradient apparently did not improve the selectivity but largely disrupted DRMs, suggesting that this condition was too strong to be used for DRM isolation. We conclude that CHAPS is not suitable for the isolation of DRMs containing MHC II and the mature invariant chain, although under some conditions, flotation of DRMs enriched in GM1 and AP could be observed.



View larger version (63K):
[in this window]
[in a new window]
  		Figure 3. Flotation of postnuclear membranes extracted with 1% CHAPS on linear 0–40% sucrose gradients in the absence (A) or the presence (B) of 1% CHAPS in the gradient. Postnuclear membranes from M12.C3.F6 were extracted with 1% CHAPS for 1 h on ice and overlayed with 0–40% linear sucrose gradients in the presence/absence of 1% CHAPS. Fractions were analyzed as detailed in the legend to Figure 1 . Note that in A, the raft markers GM1 and AP reached peak levels in fractions 5–7, whereas the other proteins partially floated to a distinct position (fractions 7–8).

 


View larger version (53K):
[in this window]
[in a new window]
  		Figure 4. Flotation of postnuclear membranes extracted with 4% CHAPS in the absence (A) or the presence (B) of the detergent in the gradient. Postnuclear membranes from M12.C3.F6 cells were extracted with 4% CHAPS for 1 h on ice and overlayed with 0–40% linear sucrose gradients with or without 4% CHAPS. Fractions were again analyzed as detailed in the legend to Figure 1 . Note that a higher degree of mature invariant chain was found in the gradient at a position to which AP was also distributed.

 
Finally, we tested the detergent Brij 98. This detergent has been reported as a mild but selective reagent for the isolation of DRMs [9 , 22 , 42 ]. In contrast to TX-100 and CHAPS, extraction of cells with Brij 98 can be done by 5 min incubation at 37°C, a temperature at which membrane lipids are in their physiological state. Figure 5 shows the distribution of the markers after extraction with 1% Brij 98 for 5 min at 37°C, followed by 1 h incubation on ice. Once again, gradients were loaded in the presence or absence of detergent. Under these conditions, GM1 and AP cofloated together with a large fraction of MHC II (40–60%). In contrast, the nonraft markers lamp-1 and B220 were absent from DRM fractions. In addition, only the mature form of the invariant chain was enriched in the raft fractions, and the ER form mostly remained soluble. The exclusion of the ER form of the invariant chain from DRMs together with the complete solubilization of B220 and lamp-1 demonstrated the higher selectivity of this detergent compared with CHAPS and TX-100. We also noticed that the TfnRc partially associated with DRMs. As this protein is considered to be nonraft-associated at the cell surface [39 ], this finding was puzzling. However, others have demonstrated with immunofluorescence techniques that TfnRc colocalizes with raft markers in endosomes [43 ]. In addition, we have shown that the fraction of TfnRc, which is floating in Brij 98, derives from intracellular TfnRc, and surface TfnRc remains soluble [9 ]. The presence of detergent in the gradient slightly decreased the flotation of MHC II and TfnRc but did not show much effect on the other proteins. In accordance, lipid analysis showed no significant differences in lipid composition of DRMs isolated in the presence or absence of detergent (Fig. 6 ). However, in comparison with total postnuclear membranes, DRMs prepared with Brij 98 showed a significantly higher abundance of cholesterol (~30% for Brij 98 DRMs vs. 18% for total postnuclear membranes) and a markedly lower content of PC (~31% for Brij 98 DRMs vs. ~47% for total postnuclear membranes). This is similar to TX-100-resistant membranes, which were prepared in the presence of detergent in the gradient (Fig. 2) . However, in the latter case, the relative abundance of Sm/PI was also significantly higher than in postnuclear membranes (Fig. 2) , whereas with Brij 98 DRMs, the minor increase over the value for postnuclear membranes remained insignificant. Taken together, we conclude that both Brij 98 protocols allow efficient and specific isolation of DRMs containing MHC II and the mature invariant chain. These DRMs are similar in their lipid composition to the TX-100-resistant membranes prepared in the presence of the detergent in the gradient.



View larger version (57K):
[in this window]
[in a new window]
  		Figure 5. Flotation of postnuclear membranes extracted with 1% Brij 98 in the absence (A) or the presence (B) of the detergent in 0–40% linear sucrose gradients. Postnuclear membranes from M12.C3.F6 cells were extracted with 1% Brij 98 for 5 min at 37°C followed by 1 h on ice. Samples were overlayed with 0–40% linear sucrose gradients with or without 1% Brij 98. Fractions were analyzed as detailed in the legend to Figure 1 . Note that a sizeable fraction of MHC II and almost all the mature invariant chain floated to DRM fractions marked by GM1 and AP, and only a little immature invariant chain and no lamp-1 were found in the gradients.

 


View larger version (20K):
[in this window]
[in a new window]
  		Figure 6. Lipid composition of Brij 98-resistant membranes isolated from gradients with or without detergent in comparison with total postnuclear membranes. Lipids were extracted from membrane pellets as described in Materials and Methods, separated by HPTLC, stained with primulin, and quantified with NIH Image. The relative abundance of lipids per sample was calculated under the assumption that all lipids showed a similar molar primulin adsorption. Sm and PI were quantified together, as already explained in the legend for Figure 2 . The data represent the mean of three independent experiments, and error bars indicate the SD. Note the high abundance of cholesterol and the lower level of PC in DRMs compared with the postnuclear membranes.

 
To evaluate the biological activity of the MHC II-containing DRMs prepared by the Brij 98 method, we pulsed M12.C3.F6 cells for 24 h with HEL and then isolated DRMs in the continued presence of Brij 98. We have previously shown that Brij 98-resistant membranes are highly enriched in complexes between the MHC II molecule Ak and the immunodominant HEL peptide 48–61 [9 ]. To investigate whether these complexes can activate T cells when present in DRMs, we removed free detergent from the DRMs by washes with PBS and then coincubated the DRMs, and the T cell hybridoma line 3A9 specific for HEL 48–61 bound to the MHC II molecule Ak [34 ]. Activation by DRMs was compared with activation by intact cells that were fed with HEL under the same conditions (Fig. 7A ). We found that Brij 98-resistant membranes from HEL-fed M12.C3.F6 cells could indeed activate 3A9 T cell hybridoma cells, albeit at a lower level than intact cells. When the same procedure was performed with TX-100-resistant membranes prepared in the presence of TX-100 in the gradients, we did not detect any activation of 3A9 cells (Fig. 7B) . This lack of activation was not caused by any inhibitory effect of traces of detergent possibly present in the DRM preparation, as a mixing experiment of DRMs prepared from B cells not exposed to HEL with intact, HEL-treated B cells showed only little reduction in the 3A9 response (Fig. 7B) . These results therefore confirm our biochemical findings that Brij 98-resistant membranes enrich peptide-loaded MHC II molecules in contrast to TX-100-resistant membranes, which evidently contain too low amounts of MHC II-peptide complexes to drive antigen presentation.



View larger version (23K):
[in this window]
[in a new window]
  		Figure 7. Antigen presentation by DRMs. M12.C3.F6 cells were cultured with 2 µM HEL for 24 h, and aliquots (1x104 cells) were cocultured with 3A9 T cells specific for HEL 48–62 (1x105 cells). Alternatively, DRMs were isolated from HEL-pulsed cells in the presence of 1% Brij 98 or 1% TX-100 throughout the procedure. For presentation, PBS-washed DRMs (approximately 1x106 cell equivalents) were cocultured with 1 x 105 3A9 cells. The IL-2 production by 3A9 cells was quantified with the IL-2-dependent cell line CTLL-2. Because of considerable variations in the overall [3H] thymidine incorporation between individual experiments (compare A with B), data from one out of two experiments are shown, each performed in triplicates. Error bars denote the SD of the triplicates. (A) Antigen presentation by Brij 98 DRMs prepared from M12.C3.F6 cells pulsed with 2 µM HEL. The background proliferation of CTLL-2 cells in this experiment was 390 ± 110 counts per minute (cpm). (B) Antigen presentation by TX-100 DRMs prepared from M12.C3.F6 cells pulsed with 2 µM HEL. The background proliferation of CTLL-2 cells in this experiment was 6706 ± 288 cpm. Note that TX-100 DRMs from HEL-pulsed cells did not stimulate 3A9 T cells, whereas Brij 98 DRMs from HEL-pulsed M12.C3.F6 cells did. Positive control (APCs+HEL): M12.C3.F6 cells pulsed with 2 µM HEL; mixing experiment (APCs+HEL+DRMs): M12.C3.F6 cells (1x104) pulsed with 2 µM HEL were mixed with washed TX-100 DRMs prepared from untreated M12.C3.F6 cells.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We have demonstrated here that the detergent Brij 98 extracts MHC II and (mature) invariant chain containing DRMs from M12.C3.F6 mouse B-lymphoma cells more efficiently and with higher specificity than TX-100 or CHAPS. Work from our lab and from others has already demonstrated that mild detergents such as Brij 98 or Brij 58 are suitable for this purpose [9 , 32 ], however, no direct comparison of the isolation efficiencies and specificities in different detergent was available to date.

In our hands, the TX-100 DRM isolation protocol using flotation in the absence of detergent yielded barely more than background levels of MHC II and mature invariant chain in DRM fractions (each <<5% of total). Our observations are similar to results from a number of studies about the raft association of MHC II, which used extraction with 0.5–1.0% TX-100 and flotation in detergent-free 5/30% sucrose step gradients as a readout [5 , 8 , 26 27 28 29 ]. In these studies, values for the MHC II-DRM association ranging from 1% to 5% have been reported for unstimulated B cells, dendritic cells (DCs), and monocytes with usually undetectable levels of background flotation. In some instances, however, a substantially higher DRM association of MHC II using similar TX-100-based isolation procedures has been shown [6 , 8 , 10 , 29 , 30 ]. These higher values may have been obtained for different reasons (for a discussion of the results reported in ref. [30 ], see ref. [9 ]). In some studies, a higher DRM association of MHC II was reported after surface cross-linking with mAb against MHC II and appropriate "secondary" antibodies, a regimen described to induce clustering to microscopically visible lipid rafts at the cell surface [39 ]. This was also shown to lead to an incremental increase in DRM association of MHC II [5 , 8 , 27 ]. Another way to increase the association of MHC II molecules with TX-100-resistant membranes appears to be the maturation of DCs [29 ] or the loading of MHC II with a high-affinity peptide [10 ]. As mature DCs present an edited set of peptides on MHC II, which differs from the one in immature DCs [44 ], the underlying molecular cause for both observations may be identical. This interpretation is consistent with results from an earlier study about the association of MHC II with Brij 98-resistant membranes, demonstrating that MHC II-bound peptides modulate the recruitment of their carrier molecule to DRMs [9 ]. This effect may also explain differences between some B cell lymphoma lines, where in some instances, a slightly higher association of MHC II with TX-100-resistant membranes was found (10–20% of total compared with 1–5% found for most unstimulated APCs) [6 , 10 ]. It is interesting that none of these studies used TX-100 in the sucrose gradients to rule out artifactual flotation. As shown in Figure 1B , we did not observe any flotation of MHC II in the presence of TX-100 in the gradient, although genuine raft markers still were afloat. This and the altered lipid composition of DRMs isolated with TX-100 in the gradient (Fig. 2) suggest that membrane domains containing MHC II (and mature invariant chain) differ from those containing only conventional raft markers.

A similar conclusion was reached when we analyzed the association of MHC II and the mature invariant chain with CHAPS-resistant membranes in comparison with conventional lipid raft markers. We were unable to achieve significant, specific flotation of MHC II (and the mature invariant chain) using this detergent. This is in line with data by others, who also have noted that total MHC II from a B cell line does not distribute to DRMs after CHAPS extraction [45 ]. By contrast, MHC II isolated from multivesicular endosomes and exosomes efficiently partitioned to CHAPS-resistant membrane fractions along with tetraspanins [45 ]. In fact, a minor subpopulation of MHC II (<5–10% of total MHC II in B cells) molecules has been shown to associate with tetraspanin networks [26 ], and its low abundance in cellular membranes may prevent its unequivocal detection above background flotation.

In contrast to TX-100 and CHAPS, the presence or absence of Brij 98 from the gradients produced only little difference in the flotation of raft markers, MHC II, and the mature invariant chain. This result was confirmed by lipid analysis, which yielded almost identical values for both DRM isolation protocols. It is interesting that the lipid compositions of DRMs prepared with the Brij 98 protocols or the stringent TX-100 protocol (with detergent in the gradient) were, on one hand, quite similar to each, and conversely, they were significantly different from postnuclear membranes. By contrast, the lipid composition of DRMs prepared with the conventional TX-100 protocol, which omits the detergent from the gradient, showed more similarity to postnuclear membranes, in line with results reported by Simons and colleagues [38 ]. These results suggest that in our hands, Brij 98 procedures and the stringent TX-100 protocol yielded DRMs with lower contamination of nonraft membranes than the commonly used TX-100 protocol without detergent in the gradient [38 , 41 ]. Despite these similarities between the DRMs prepared with the stringent TX-100 protocol and the Brij 98-based procedures, there were also differences: Proteins such as MHC II, the mature invariant chain, and endosomal TfnRc [9 ] were only present in Brij 98 DRMs, whereas the relative abundance of SM/PI was lower in these DRMs. These data are compatible with the interpretation that Brij 98 DRMs selectively contain additional membrane components in comparison with DRMs isolated by the stringent TX-100 protocol. This view is supported by data about the ability of Brij 98 DRMs to activate T cells and the inability of TX-100 DRMs to do so, which apparently did not contain sufficient MHC II-peptide complexes to drive antigen presentation. To our knowledge, this is the first measurement of T cell activation by isolated DRMs reported in the literature.

To date, there is a small number of untypical raft proteins, which show a similar type of behavior to what we described here, such as the TCR complex [22 ], the microvillus protein prominin [20 ], or the prion protein [19 , 25 ]. These proteins remain mostly soluble when extracted with 1% TX-100 but resist extraction by milder detergents such as Brij 96, Lubrol WX, or Brij 98. For these three proteins, evidence has been provided that differential detergent sensitivity correlates with localization to distinct and separate membrane patches at the cell surface [19 , 20 , 25 ], with differential enrichment in immunoisolated DRMs [19 , 22 , 25 ] or with a partial but direct biophysical separation on linear flotation gradients [20 ]. All of this suggests that the TCR complex, prominin, and the prion protein indeed localize to membrane domains distinct and physically separated from conventional lipid rafts. The changes we observed in lipid composition upon inclusion of TX-100 in the flotation gradients, the elimination of floating MHC II and the mature invariant chain under this condition, and the efficient and specific flotation of these two proteins in Brij 98 show that MHC II and the mature invariant chain follow a similar pattern and thus, strongly suggest that they also localize to membrane domains distinct from conventional lipid rafts. It is interesting in this respect that MHC II (this work) and the TCR [22 , 46 , 47 ] appear to prefer a closely related or identical membrane environment. This may result in a similar packing geometry of these proteins, which may favor the corecruitment of this receptor-ligand pair into the dense center of mature, immunological synapses. At present, however, our data do not rule out the possibility that MHC II, the mature invariant chain, and other membrane components are associated with the edges of a TX-100-resistant "core raft" [48 ] and thus, do not form a separate entity. Immunoisolation experiments should help to distinguish between these two possibilities in the future.


   ACKNOWLEDGEMENTS
 
This work was supported by a grant from the German Research Foundation (SFB 621 to R. L.). We thank Gudrun Daenecke for technical assistance and Cristian Gavan for the HPTLC protocol. Dr. Rudi Bauerfeind, Dr. Ruth Knorr, and Dr. Ernst Ungewickell are thanked for comments about the manuscript.

Received April 12, 2005; revised June 23, 2005; accepted July 15, 2005.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Cresswell, P. (1994) Assembly, transport, and function of MHC class II molecules Annu. Rev. Immunol. 12,259-293[CrossRef][Medline]
  2. Busch, R., Doebele, R. C., Patil, N. S., Pashine, A., Mellins, E. D. (2000) Accessory molecules for MHC class II peptide loading Curr. Opin. Immunol. 12,99-106[CrossRef][Medline]
  3. Hiltbold, E. M., Roche, P. A. (2002) Trafficking of MHC class II molecules in the late secretory pathway Curr. Opin. Immunol. 14,30-35[CrossRef][Medline]
  4. Trombetta, E. S., Mellman, I. (2005) Cell biology of antigen processing in vitro and in vivo Annu. Rev. Immunol. 23,975-1028[CrossRef][Medline]
  5. Huby, R. D., Dearman, R. J., Kimber, I. (1999) Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts J. Biol. Chem. 274,22591-22596[Abstract/Free Full Text]
  6. Anderson, H. A., Hiltbold, E. M., Roche, P. A. (2000) Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation Nat. Immunol. 1,156-162[Medline]
  7. Hiltbold, E. M., Poloso, N. J., Roche, P. A. (2003) MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse J. Immunol. 170,1329-1338[Abstract/Free Full Text]
  8. Becart, S., Setterblad, N., Ostrand-Rosenberg, S., Ono, S. J., Charron, D., Mooney, N. (2003) Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling J. Cell Sci. 116,2565-2575[Abstract/Free Full Text]
  9. Karacsonyi, C., Knorr, R., Fülbier, A., Lindner, R. (2004) Association of major histocompatibility complex II with cholesterol- and sphingolipid-rich membranes precedes peptide loading J. Biol. Chem. 279,34818-34826[Abstract/Free Full Text]
  10. Setterblad, N., Becart, S., Charron, D., Mooney, N. (2004) B cell lipid rafts regulate both peptide-dependent and peptide-independent APC-T cell interaction J. Immunol. 173,1876-1886[Abstract/Free Full Text]
  11. Simons, K., Ikonen, E. (1997) Functional rafts in cell membranes Nature 387,569-572[CrossRef][Medline]
  12. Brown, D. A., London, E. (1998) Functions of lipid rafts in biological membranes Annu. Rev. Cell Dev. Biol. 14,111-136[CrossRef][Medline]
  13. Edidin, M. (2003) The state of lipid rafts: from model membranes to cells Annu. Rev. Biophys. Biomol. Struct. 32,257-283[CrossRef][Medline]
  14. Sharma, P., Varma, R., Sarasij, R.C., Ira, Gousset, , K., Krishnamoorthy, G., Rao, M., Mayor, S. (2004) Nanoscale organization of multiple GPI-anchored proteins in living cell membranes Cell 116,577-589[CrossRef][Medline]
  15. Subczynski, W. K., Kusumi, A. (2003) Dynamics of raft molecules in the cell and artificial membranes: approaches by pulse EPR spin labeling and single molecule optical microscopy Biochim. Biophys. Acta 1610,231-243[Medline]
  16. Simons, K., Toomre, D. (2000) Lipid rafts and signal transduction Nat. Rev. Mol. Cell Biol. 1,31-39[CrossRef][Medline]
  17. Ikonen, E. (2001) Roles of lipid rafts in membrane transport Curr. Opin. Cell Biol. 13,470-477[CrossRef][Medline]
  18. van der Goot, F. G., Harder, T. (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack Sem. Immunol. 13,89-97[CrossRef][Medline]
  19. Madore, N., Smith, K. L., Graham, C. H., Jen, A., Brady, K., Hall, S., Morris, R. (1999) Functionally different GPI proteins are organized in different domains on the neuronal surface EMBO J. 18,6917-6926[CrossRef][Medline]
  20. Röper, K., Corbeil, D., Huttner, W. B. (2000) Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane Nat. Cell Biol. 2,582-592[CrossRef][Medline]
  21. Gomez-Mouton, C., Abad, J. L., Mira, E., Lacalle, R. A., Gallardo, E., Jimenez-Baranda, S., Illa, I., Bernad, A., Manes, S., Martinez, A. C. (2001) Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization Proc. Natl. Acad. Sci. USA 98,9642-9647[Abstract/Free Full Text]
  22. Drevot, P., Langlet, C., Guo, X. J., Bernard, A. M., Colard, O., Chauvin, J. P., Lasserre, R., He, H. T. (2002) TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts EMBO J. 21,1899-1908[CrossRef][Medline]
  23. Drobnik, W., Borsukova, H., Bottcher, A., Pfeiffer, A., Liebisch, G., Schutz, G. J., Schindler, H., Schmitz, G. (2002) Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains Traffic 3,268-278[CrossRef][Medline]
  24. Slimane, T. A., Trugnan, G., Van, I. S. C., Hoekstra, D. (2003) Raft-mediated trafficking of apical resident proteins occurs in both direct and transcytotic pathways in polarized hepatic cells: role of distinct lipid microdomains Mol. Biol. Cell 14,611-624[Abstract/Free Full Text]
  25. Brügger, B., Graham, C., Leibrecht, I., Mombelli, E., Jen, A., Wieland, F., Morris, R. (2004) The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition J. Biol. Chem. 279,7530-7536[Abstract/Free Full Text]
  26. Kropshofer, H., Spindeldreher, S., Rohn, T. A., Platania, N., Grygar, C., Daniel, N., Wolpl, A., Langen, H., Horejsi, V., Vogt, A. B. (2002) Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes Nat. Immunol. 3,61-68[CrossRef][Medline]
  27. Setterblad, N., Roucard, C., Bocaccio, C., Abastado, J. P., Charron, D., Mooney, N. (2003) Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells J. Leukoc. Biol. 74,40-48[Abstract/Free Full Text]
  28. Bouillon, M., El Fakhry, Y., Girouard, J., Khalil, H., Thibodeau, J., Mourad, W. (2003) Lipid raft-dependent and -independent signaling through HLA-DR molecules J. Biol. Chem. 278,7099-7107[Abstract/Free Full Text]
  29. Meyer zum Bueschenfelde, C. O., Unternaehrer, J., Mellman, I., Bottomly, K. (2004) Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells J. Immunol. 173,6119-6124[Abstract/Free Full Text]
  30. Dolan, B. P., Phelan, T. P., Ilkovitch, D., Qi, L., Wade, W. F., Laufer, T. M., Ostrand-Rosenberg, S. (2004) Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines J. Immunol. 172,907-914[Abstract/Free Full Text]
  31. Vogt, A. B., Spindeldreher, S., Kropshofer, H. (2002) Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains Immunol. Rev. 189,136-151[CrossRef][Medline]
  32. Poloso, N. J., Muntasell, A., Roche, P. A. (2004) MHC class II molecules traffic into lipid rafts during intracellular transport J. Immunol. 173,4539-4546[Abstract/Free Full Text]
  33. Nabavi, N., Ghogawala, Z., Myer, A., Griffith, I. J., Wade, W. F., Chen, Z. Z., McKean, D. J., Glimcher, L. H. (1989) Antigen presentation abrogated in cells expressing truncated Ia molecules J. Immunol. 142,1444-1447[Abstract]
  34. Allen, P. M., Unanue, E. R. (1984) Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas J. Immunol. 132,1077-1079[Medline]
  35. Oi, V. T., Jones, P. P., Goding, J. W., Herzenberg, L. A. (1978) Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens Curr. Top. Microbiol. Immunol. 81,115-120[Medline]
  36. Koch, N., Koch, S., Hämmerling, G. J. (1982) Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody Nature 299,644-645[CrossRef][Medline]
  37. Gillis, S., Ferm, M. M., Ou, W., Smith, K. A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity J. Immunol. 120,2027-2032[Abstract/Free Full Text]
  38. Schuck, S., Honsho, M., Ekroos, K., Shevchenko, A., Simons, K. (2003) Resistance of cell membranes to different detergents Proc. Natl. Acad. Sci. USA 100,5795-5800[Abstract/Free Full Text]
  39. Harder, T., Scheiffele, P., Verkade, P., Simons, K. (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components J. Cell Biol. 141,929-942[Abstract/Free Full Text]
  40. Hammond, C., Denzin, L. K., Pan, M., Griffith, J. M., Geuze, H. J., Cresswell, P. (1998) The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules J. Immunol. 161,3282-3291[Abstract/Free Full Text]
  41. Brown, D. A., Rose, J. K. (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface Cell 68,533-544[CrossRef][Medline]
  42. Braccia, A., Villani, M., Immerdal, L., Niels-Christiansen, L. L., Nystrom, B. T., Hansen, G. H., Danielsen, E. M. (2003) Microvillar membrane microdomains exist at physiological temperature. Role of galectin-4 as lipid raft stabilizer revealed by "superrafts" J. Biol. Chem. 278,15679-15684[Abstract/Free Full Text]
  43. Sharma, D. K., Choudhury, A., Singh, R. D., Wheatley, C. L., Marks, D. L., Pagano, R. E. (2003) Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling J. Biol. Chem. 278,7564-7572[Abstract/Free Full Text]
  44. Rohn, T. A., Boes, M., Wolters, D., Spindeldreher, S., Muller, B., Langen, H., Ploegh, H., Vogt, A. B., Kropshofer, H. (2004) Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization Nat. Immunol. 5,909-918[CrossRef][Medline]
  45. Wubbolts, R., Leckie, R. S., Veenhuizen, P. T., Schwarzmann, G., Mobius, W., Hoernschemeyer, J., Slot, J. W., Geuze, H. J., Stoorvogel, W. (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation J. Biol. Chem. 278,10963-10972[Abstract/Free Full Text]
  46. Montixi, C., Langlet, C., Bernard, A. M., Thimonier, J., Dubois, C., Wurbel, M. A., Chauvin, J. P., Pierres, M., He, H. T. (1998) Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains EMBO J. 17,5334-5348[CrossRef][Medline]
  47. Xavier, R., Brennan, T., Li, Q., McCormack, C., Seed, B. (1998) Membrane compartmentation is required for efficient T cell activation Immunity 8,723-732[CrossRef][Medline]
  48. Pike, L. J. (2004) Lipid rafts: heterogeneity on the high seas Biochem. J. 378,281-292[CrossRef][Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Chentouf, S. Ghannam, C. Bes, S. Troadec, M. Cerutti, and T. Chardes
Recombinant Anti-CD4 Antibody 13B8.2 Blocks Membrane-Proximal Events by Excluding the Zap70 Molecule and Downstream Targets SLP-76, PLC{gamma}1, and Vav-1 from the CD4-Segregated Brij 98 Detergent-Resistant Raft Domains
J. Immunol., July 1, 2007; 179(1): 409 - 420.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Hunter and G. F. Nixon
Spatial Compartmentalization of Tumor Necrosis Factor (TNF) Receptor 1-dependent Signaling Pathways in Human Airway Smooth Muscle Cells: LIPID RAFTS ARE ESSENTIAL FOR TNF-{alpha}-MEDIATED ACTIVATION OF RhoA BUT DISPENSABLE FOR THE ACTIVATION OF THE NF-{kappa}B AND MAPK PATHWAYS
J. Biol. Chem., November 10, 2006; 281(45): 34705 - 34715.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Vaisanen, M.-R. Vaisanen, and T. Pihlajaniemi
Modulation of the Cellular Cholesterol Level Affects Shedding of the Type XIII Collagen Ectodomain
J. Biol. Chem., November 3, 2006; 281(44): 33352 - 33362.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0405189v1
78/5/1097    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karacsonyi, C.
Right arrow Articles by Lindner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karacsonyi, C.
Right arrow Articles by Lindner, R.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS